Journals / Tüberküloz ve Toraks / 2014 / Cilt: 62 - Sayı: 1

The Treatment of central sleep-ap neas yndrome, updated ın formation, and review of the literature

Santral uyku apne sendromu tedavisi, güncel bilgiler ve literatürün gözden geçiril mesirevıew

Pages
68–78
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In th isreview, our aim is to ana lyze treatment a lternatives for CSAS inth e ligh t of currently update d information.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Centra l s lee p-a pnea s yn drome (CSAS) is a disease state ch aracterize d by respiratory arrest as a resu lt of decrease or lack o f respir-ofatory drive originatin g from respiratory center.
📊
Key Findings & Data:Althou gh it is seen in less than 5% of the casses who consult to the sleep d sordersdiscenter, incidence of CSAS increases in the presence of con gestive heart and/or renal failure, and central nervous system a bb normal-bities.
💡
Conclusion & Impact:In th isreview, our aim is to ana lyze treatment a lternatives for CSAS inth e ligh t of currently update d information.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Centra l s lee p-a pnea s yn drome (CSAS) is a disease state ch aracterize d by respiratory arrest as a resu lt of decrease or lack o f respir-ofatory drive originatin g from respiratory center. Althou gh it is seen in less than 5% of the casses who consult to the sleep d sordersdiscenter, incidence of CSAS increases in the presence of con gestive heart and/or renal failure, and central nervous system a bb normal-bities. Treatment of CSAS which has been analyzed under six h ea din gs in th e last version of Internationa l Classification of S leepDisorders (ICSD-2), differs among each type of CSAS. In th isreview, our aim is to ana lyze treatment a lternatives for CSAS inth e ligh t of currently update d information.

Özet

Santra l u yku a pne sen dromu (centra l s lee p a pnea sy n drome, CSAS); solunum merkezin den ka y na klanan so lunum dürtüsü nn ün aza l-nmas ı ve ya ka yb o lması sonucu u yku da so lunum durmasıyla kara kterize b ir hasta lık ta blosudur. U yku b ozu klu kları merkezin e b a şvu -neran o lgu ların %5in den azın da görü lme kle b irlikte, kon jestif ka lp yetmezliği, b ö b re k yetmez liği, santra l sinir sistemi pato lojilerininlovarlığın da CSAS görü lme oran ı artar. U luslararası Uy ku Bozu klu kları Sın ıflamasın ın son versiyonun da (Internationa l Classification of icSleep Disorders, ICSD-2) a ltı b a şlıkta toplanm ış o lan CSASın te davisi, h er b ir CSAS tipi için ayrıca lık gösterir. Bu derlem e de CSASedtedavi yakla şımların ın güncel bilgiler ışığında gözden geçirilmesi amaçlanm ıştır.

🔖

Cite This Article

KANBAY, A., İNÖNÜ, H. K., KÖKTÜRK, O. (2022). The Treatment of central sleep-ap neas yndrome, updated ın formation, and review of the literature. Tüberküloz ve Toraks, Cilt: 62 - Sayı: 1, 68–78. https://ajindex.com/articles/618608

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Momomura S. Treatment of Ch e y ne-Sto k es respiration - c entra l slee p a pnea in patients with h eart failure. J Cardio lo gy 2012;59:110-6
  2. Eckert DJ, Jordan AS, Merc h ia P, Ma lh otr A. Centra l slee p apnea. Path oph ysio logy an d treatment. Ch es t 2007;131:595-607
  3. Silva CP, Filho GL, Marcon des B, Junior GO, Man gini S. Re duction of centra l slee p a pnea in heart failure patients with b eta-blockers th era py. Arq Bras Cardio l 2010;94:223-9
  4. American Aca dem y of S lee p Me dicine: Internationa l clas- sification of sleep disorders. Dia gnostic an d co din g manu - al, 2 nd ed. Westchester, Illinois: American Academy of d S lee p Me dicine 2005
  5. Xie A, Ran kin F, Ruth erford R, Bra dle y T. Effects of in h a le d CO 2 an d a dde d dea d s pace on idio path ic centra l slee p a pnea. J Appl Physio l 1997;82:918-26
  6. Aurora RN, Ch ow dh uri S, Ramar K, Bista SR, Case y KR, Lamm CI, et al. The treatment of central slee p a pnea syn - dromes in a du lts: practice parameters with an evidence - b ase d literature review an d meta-ana lyses. Slee p 2012;35:17-40
  7. DeBacker W, Verb raeck en J, Willemen M, Wittesae le W, DeCock W, et a l. Centra l a pnea in dex decreases after pro - lon ge d treatment with acetazo lamide. Am J Respir Crit Care Med 1995;151:87-91
  8. W h ite D, Zwillic h C, Pickett C, Dou glas N, Fin dley L, Weil J. Centra l slee p a pnea: im provement with acetazo lamide th era py. Arch Intern Me d 1982;142:1816-9
  9. Qua dri S, Dra ke C, Hu dge l DW. Improvement of idiopath- ic centra l s lee p a pnea with zolpidem. J Clin S lee p Me d 2009;5:122-9
  10. Bonnet M, Dexter J, Aran d D. T h e effect of triazo lam on arousa l an d respiration in centra l slee p a pnea patients. S lee p 1990;13:31-41
  11. Lanfranch i PA, Bra gh iroli A, Bosimini E, Mazzuero G, Co lom b o R, Donner CF, et a l. Prognostic va lue of noctur- na l Ch e yne-Sto k es respiration in ch ronic h eart failure. Circu lation 1999;99:1435-40
  12. Tamura A, Kawano Y, Ka dota J. Carve dilo l re duces th e severity of centra l s lee p a pnea in c h ronic h eart failure. Circ J 2009;73:295-8
  13. Wa lsh J, An drews R, Starling R, Cow ley A, Jo h nston I, Kinnear W. Effects of captopril and oxy gen on sleep apnoea in patients with mild to mo derate con gestive car- diac failure. Br Heart J 1995; 73:237-41
  14. Zilb erman M, Silverb erg D, Bits I, Steinb ruch S, Wexler D, Sh e ps D, et a l. Im provement of anemia with ery th ro poietin